Switch to
Place Order
Kilitch Drugs (India) Ltd
KILITCH
157.651.05 (-0.66%)
Investment Checklist
BasicPro
Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD
Stock has not been able to generate better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Kilitch Drugs (India) Ltd
KILITCH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,418
High RiskStock is 3.12x as volatile as Nifty
157.651.05 (-0.66%)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data
Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD
Stock has not been able to generate better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Health CarePharmaceuticals
SmallcapWith a market cap of ₹245 cr, stock is ranked 1,418
High RiskStock is 3.12x as volatile as Nifty
Key Metrics
PE RatioPE Ratio
67.03
PB RatioPB Ratio
2.04
Dividend YieldDiv. Yield
—
Sector PESector PE
38.17
Sector PBSector PB
5.69
Sector Div YldSctr Div Yld
0.66%
Forecast & RatingsDetailed Forecast
—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Kilitch Drugs (India) Limited is engaged in the development and operations of pharmaceutical business. The Company's services range from manufacturing to marketing a host of formulations in solid, liquid and parenteral forms.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
PE Ratio
54.74
1Y Return
32.93%
Buy Reco %
77.78
Dr Reddy's Laboratories Ltd
PE Ratio
45.01
1Y Return
28.97%
Buy Reco %
83.33
Cipla Ltd
PE Ratio
31.95
1Y Return
45.16%
Buy Reco %
83.33
Cadila Healthcare Ltd
PE Ratio
30.60
1Y Return
69.88%
Buy Reco %
43.75
Aurobindo Pharma Ltd
PE Ratio
10.37
1Y Return
17.42%
Buy Reco %
85.19
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data